The y interferon (,y-IFN) concentration and the adenosine deaminase (ADA) activity were evaluated in 30 patients with tuberculous peritonitis, 21 patients with ascites due to a malignant disorder, and 41 patients with cirrhosis. The y-IFN concentrations were significantly higher (p<0.0001) in tuberculous peritonitis patients (mean: 6-70 U/ml) than in the malignant (mean: 3.10 U/ml) and cirrhotic (mean: 3.08 U/ml) groups. Use of a cut off value of ¢3.2 U/mli gave the assay a sensitivity of93% (25 of 27), a specificity of 98% (54 of 55), positive (P+) and negative (P-) (Gut 1995; 36: 419-421) 
concentrations were significantly higher (p<0.0001) in tuberculous peritonitis patients (mean: 6-70 U/ml) than in the malignant (mean: 3.10 U/ml) and cirrhotic (mean: 3.08 U/ml) groups. Use of a cut off value of ¢3.2 U/mli gave the assay a sensitivity of93% (25 of 27), a specificity of 98% (54 of 55), positive (P+) and negative (P-) predictive values of 96% and a test accuracy of 96%. The ADA activity was significantly (p<0-0001) higher in the tuberculous peritonitis group 19.35 U/I)) (p<00001). There was no significant difference between the cirrhotic and malignant groups (p<O 1099).
The y-IFN concentrations were determined in 82 of 92 patients. Individual ascitic y-IFN values in the different groups are shown in Figure 1B . The cirrhotic (range: 3.014-3 184 U/ml; mean: 3.087 U/ml) and malignant (range: 3.053-3.363 U/ml; mean: 3.104 U/ml) groups had significantly (p<0 0001) lower ,y-IFN values than the TB group (range: 3.079-25.704 U/ml; mean 6.70 U/ml). The difference in the y-IFN concentrations between the cirrhotic and the malignancy groups was not significant (p<0 6564) and the two were combined to form the control group (mean: 3.0955+0.052 U/ml).
There was a significant (p<0 0001) correlation (r= 0.72) between ADA activity and y-IFN values in the tuberculous peritonitis group only (Figure 2 ). 
success rate (these authors did not indicate the volume of ascitic fluid used). When larger volumes of ascitic fluid (one litre concentrated either by centrifugation or sedimentation) were used, improved culture rates of 63% (five of eight)18 and 83% (39 of 47)20 have been reported. Concentrating one litre of ascitic fluid by sedimentation improved the culture rate to 52% (14 of 27) in this study. Irrespective of the volume of ascitic fluid used, culture of ascitic fluid takes three to eight weeks, which limits its diagnostic usefulness. Thus, some other investigation is almost always necessary. The sensitivity (93%) and specificity (96%) of the ADA activity in our study confirms our previous observations13 and those made by other researchers.8-'2 16 There were two false negative ADA results. One was a patient with HIV and TB and the other a patient whose diagnosis was established only on the basis of a positive culture of M tuberculosis.
ADA activity has been reported to be significantly lower in patients with AIDS related tuberculous peritonitis'6 and in those patients in whom the ascitic protein concentration is low.8 The latter patient had a total ascitic protein concentration of 42 g/l (normal: 60-80 g/l). The two false positive ADA results occurred in patients with ascites due to malignancies, an observation that has been reported by others.11 16 Ribera et al 16 recently reported high y-IFN concentrations in 16 patients with tuberculous peritonitis. In their hands the test had a sensitivity and specificity of 100%. The sensitivity and specificity of the -y-IFN test in our study may be influenced by the fact that tuberculous peritonitis is endemic in our environment2
and, perhaps, the manner in which the sample was prepared for the assay. Unlike Ribera et al,16 we observed a significant correlation between the ADA activity and y-IFN values in patients with tuberculous peritonitis.
The -y-IFN values in the two TB patients who were also seropositive for HIV (3.3 U/ml), were closer to the cut off level, but high enough to differentiate between TB and non-TB. The ADA activity was <30 U/1 in only one HIV positive patient (0.8 U/l). Ribera 
